News

News

Year 2026

  • ACTRIMS-ECTRIMS 2026 Best Young Investigator Poster Awards

    At the 10th Joint ACTRIMS-ECTRIMS Congress 2026 in Toronto, the study led by Dr Alessandro Cruciani (San Camillo-Forlanini Hospital, Rome) entitled “Education Expands the Window of Preserved Function in Multiple Sclerosis” was awarded the prize for Best Young Investigator Poster.

  • ECTRIMS booklet 2026

    RISM 2026 Congress booklet

  • RISM contributions to ACTRIMS-ECTRIMS 2026

    Presenting Author Title Presentation Type (Oral/Poster) Session, Date (GMT-4)
    Damiano Paolicelli Profiling the long-term risk of Severe Adverse Events in a cohort of Multiple Sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study) Oral
    (O104)
    Free Communications Session 5, 22 Oct 2026, 10:30 AM-10:40 AM
    Pasquale Paletta Accelerating Diagnosis and Treatment in Pediatric Onset Multiple Sclerosis: 25 Years of Real-World Evidence from the Italian Multiple Sclerosis and Related Disorders Register Poster (P0036) Poster Session 1, 21 Oct 2026
    Davide Quartana Incidence and Risk Factors for Pneumonia in a Prospective, Real-World, Multicentric Cohort of Multiple Sclerosis Patients Treated With Anti-CD20 Monoclonal Antibodies Poster (P0454) Poster Session 1, 21 Oct 2026
    Alessandro Cruciani
    Carla Tortorella
    Education Expands the Window of Preserved Function in Multiple Sclerosis Poster (P1091) Poster Session 2, 22 Oct 2026
    Pietro Iaffaldano Earlier diagnosis is associated with improved disability outcomes in Primary Progressive Multiple Sclerosis: impact of McDonald criteria revisions in a large real-world cohort ePoster (EP2230) ePoster
    Marco Salivetto European Mapping of Multiple Sclerosis Registries for the Evaluation of Safety Outcomes: A Scoping Review ePoster (EP2747) ePoster


  • Year 2025

    A study with data from the Italian MS Register wins the ECTRIMS' Best Poster Award

    The study conducted by Professor Emilio Portaccio (University of Florence - Careggi Hospital) on the Progression Independent of Relapse Activity (PIRA) has been awarded

    Read the interview given to AISM

     

  • RISM contributions to ECTRIMS 2025

    First author Code Session Area Title
    Jiri Drahota P075 Paper Poster Session 1 (24/09) Clinical Aspects of MS - Epidemiology MS Research Without Borders - Accelerating Collaboration with a BMSD Common Data Model
    Pasquale Paletta P080 Paper Poster Session 1 (24/09) Clinical Aspects of MS - Epidemiology Gender trends in Multiple Sclerosis over the last 25 years: Real-World Evidence from the Italian Multiple Sclerosis and Related Disorders Register
    Tommaso Guerra P359 Paper Poster Session 1 (24/09) Therapy - Real world evidence Assessing cladribine effectiveness for secondary progressive multiple sclerosis: the experience of the Italian Multiple Sclerosis and Related Disorders Register
    Carla Tortorella P513 Paper Poster Session 2 (25/09) Clinical Aspects of MS - NMOSD & MOGAD Clinical and radiological prognostic factors in NMOSD and MOGAD. A cohort analysis by Italian MS National Registry through the implementation of a specific data set
    Emilio Portaccio P559 Paper Poster Session 2 (25/09) Clinical Aspects of MS - Progression Progression independent of relapse activity in relapsing multiple sclerosis is less smoldering than it seems
    Shalom Haggiag P850 Paper Poster Session 2 (25/09) Therapy - Real world evidence Real-World Comparison of Cladribine and S1P-Receptor Modulators in Treatment-Naive Relapsing MS: A Propensity Score-Matched Study
    Aurora Zanghì P1187 ePoster Clinical Aspects of MS - Progression Multiple Sclerosis from onset to secondary progression: a 30-years Italian register study
    Marco Salivetto P1777 ePoster Therapy - Real world evidence Real-world data sources for the collection of safety events: the experience of the Italian Multiple Sclerosis and Related Disorders Register
    Michela Ponzio P1834 ePoster Therapy - Real world evidence Safety of Glatiramer Acetate in Real-World People with MS: Insights from the Italian Multiple Sclerosis and Related Disorders Register
    Pasquale Paletta P1238 ePoster Clinical Aspects of MS - Pregnancy and gender aspects Gender and Multiple Sclerosis in the real-world: what remains after matching? A propensity score study from the Italian Multiple Sclerosis and Related Disorders Register

Year 2024


Year 2023


Year 2022


Year 2019


Privacy Policy

Fondazione Italiana Sclerosi Multipla – FISM – Ente del Terzo Settore/ETS e, in forma abbreviata, FISM ETS.
Iscrizione al RUNTS Rep. N° 89695 - Fondazione con Riconoscimento di Personalità Giuridica - C.F. 95051730109